Currently, the stock price of Capricor Therapeutics Inc (CAPR) is $6.27. In the most recent trading session, the stock underwent a significant upswing, peaking at $77.0 after opening at $6.27. The stock touched a low of $20.0 before closing at $6.88.
The market performance of Capricor Therapeutics Inc has been somewhat unstable.
52-week price history of CAPR Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Capricor Therapeutics Inc’s current trading price is -73.21% away from its 52-week high, while its distance from the 52-week low is 78.13%. The stock’s price range for this period has remained between $3.52 and $23.40. The Healthcare sector company’s shares managed to surpass a trading volume of around 3.51 million for the day, which was noticeably higher compared to the shares’ average daily volume of 3.02 million over the last three months.
Financial Performance and Market Capitalization
Capricor Therapeutics Inc (CAPR) has experienced a quarterly decline of -44.27% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 286.59M and boasts a workforce of 160 employees.
Analysts’ Ratings For Capricor Therapeutics Inc
As of right now, 7 analysts are rating Capricor Therapeutics Inc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 10.89, with a change in price of -9.53. Similarly, Capricor Therapeutics Inc recorded 2,465,164 in trading volume during the last 100 days, posting a change of -60.32%.
CAPR Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CAPR stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.03.
CAPR Stock Stochastic Average
As of today, the raw stochastic average of Capricor Therapeutics Inc over the past 50 days is 2.24%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 1.41%. Additionally, the Stochastic %K and %D values for the company were 10.66% and 13.95%, respectively, over the past 20 days.
CAPR Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. This year’s metric has recorded a Price increase of 30.08%. However, over the past six months, we’ve seen a stronger performance of -53.56%. The price of CAPR leaped by -47.49% over the last 30 days. And in the last five days, it has fallen by -15.10%.
